Published in Cancer Epidemiol Biomarkers Prev on April 01, 1999
Value of recruitment strategies used in a primary care practice-based trial. Contemp Clin Trials (2006) 1.74
Assessing oral literacy demand in genetic counseling dialogue: preliminary test of a conceptual framework. Soc Sci Med (2007) 1.49
Recruitment of families for genetic studies of epilepsy. Epilepsia (2005) 1.08
What's at stake? Genetic information from the perspective of people with epilepsy and their family members. Soc Sci Med (2011) 1.00
Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer (2010) 0.83
Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review. J Community Genet (2013) 0.83
Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer. J Cancer Educ (2010) 0.82
Psychosocial impact of Peutz-Jeghers Syndrome. Fam Cancer (2008) 0.81
Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study. J Genet Couns (2015) 0.75
Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges. Clin Pharmacol Ther (2007) 3.04
Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet (1994) 2.06
Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes (2000) 1.97
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics (2011) 1.69
Workforce projections for optometry. Optometry (2000) 1.52
Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet (1988) 1.46
Glucose- and GTP-dependent stimulation of the carboxyl methylation of CDC42 in rodent and human pancreatic islets and pure beta cells. Evidence for an essential role of GTP-binding proteins in nutrient-induced insulin secretion. J Clin Invest (1996) 1.35
The economics of clinical genetics services. I. Preview. Am J Hum Genet (1987) 1.32
Effects of obstetrician gender on communication and patient satisfaction. Obstet Gynecol (1999) 1.23
Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am (1981) 1.18
What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol (2000) 1.15
Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic beta cells. Biochem Pharmacol (1997) 1.07
Factors influencing health insurers' decisions to cover new genetic technologies. Int J Technol Assess Health Care (2000) 1.04
Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology (1996) 1.02
"Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing. Hastings Cent Rep (1997) 1.02
Altered arachidonic acid synthesis and lipid peroxidation in diabetes mellitus: possible roles in leukocyte dysfunction and other cellular defects. Med Hypotheses (1983) 1.00
Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology (1998) 1.00
Characterization of nucleoside diphosphokinase activity in human and rodent pancreatic beta cells: evidence for its role in the formation of guanosine triphosphate, a permissive factor for nutrient-induced insulin secretion. Biochemistry (1994) 1.00
Stimulation by prostaglandin E2 of a high-affinity GTPase in the secretory granules of normal rat and human pancreatic islets. Biochem J (1994) 0.98
Subcellular localization and kinetic characterization of guanine nucleotide binding proteins in normal rat and human pancreatic islets and transformed beta cells. Biochim Biophys Acta (1994) 0.96
Involving consumers in the development of an educational program for cystic fibrosis carrier screening. Am J Hum Genet (1994) 0.96
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet (2012) 0.96
A novel regulatory mechanism for trimeric GTP-binding proteins in the membrane and secretory granule fractions of human and rodent beta cells. Biochem J (1996) 0.95
Sounding board. Prostaglandins, the glucoreceptor, and diabetes. N Engl J Med (1979) 0.95
Glucose activates the carboxyl methylation of gamma subunits of trimeric GTP-binding proteins in pancreatic beta cells. Modulation in vivo by calcium, GTP, and pertussis toxin. J Clin Invest (1997) 0.94
Glucose increases the synthesis of lipoxygenase-mediated metabolites of arachidonic acid in intact rat islets. Proc Natl Acad Sci U S A (1985) 0.94
Increasing influenza vaccination adherence through voice mail. J Am Geriatr Soc (1989) 0.93
Population screening for the cystic fibrosis gene. N Engl J Med (1991) 0.93
Prenatal genetic testing: content of discussions between obstetric providers and pregnant women. Obstet Gynecol (1998) 0.93
Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. J Clin Endocrinol Metab (1979) 0.93
Plasma prostaglandin E in patients with cancer with and without hypercalcemia. J Clin Endocrinol Metab (1976) 0.92
Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism (1981) 0.92
Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathways. Diabetes (1978) 0.92
p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells. Cell Death Differ (2004) 0.92
Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis. Am J Obstet Gynecol (1981) 0.91
Lipoxygenation of arachidonic acid: a pivotal step in stimulus-secretion coupling in the pancreatic beta cell. Endocrinology (1982) 0.91
Empirical evidence that genetic counseling is directive: where do we go from here? Am J Hum Genet (1997) 0.90
A phospholipase D-like mechanism in pancreatic islet cells: stimulation by calcium ionophore, phorbol ester and sodium fluoride. Biochem Biophys Res Commun (1989) 0.90
Characterization of prenylcysteine methyltransferase in insulin-secreting cells. Biochem J (1996) 0.89
Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Lett (1997) 0.89
Rapid extraction of leukotrienes from biologic fluids and quantitation by high-performance liquid chromatography. J Chromatogr (1982) 0.89
Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas. Diabetes (1981) 0.89
Krukenberg carcinoma of the ovary with bone marrow involvement. Report of 2 cases and review of the literature. Obstet Gynecol (1980) 0.89
Obesity in achondroplasia. Am J Med Genet (1988) 0.88
Is phospholipase A2 a "glucose sensor" responsible for the phasic pattern of insulin release? Prostaglandins (1984) 0.87
Use of a soluble tetrazolium compound to assay metabolic activation of intact beta cells. Metabolism (1998) 0.86
Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing. Oncol Nurs Forum (2000) 0.86
Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid. Diabetes (1984) 0.86
Phasic effects of glucose, phospholipase A2, and lysophospholipids on insulin secretion. Endocrinology (1987) 0.86
Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. Biochem Biophys Res Commun (1986) 0.86
Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics (1993) 0.85
Regulation of guanine-nucleotide binding proteins in islet subcellular fractions by phospholipase-derived lipid mediators of insulin secretion. Biochim Biophys Acta (1994) 0.85
Mothers and daughters from breast cancer families: a qualitative study of their perceptions of risks and benefits associated with minor's participation in genetic susceptibility research. J Am Med Womens Assoc (2000) 0.85
Phasic glucose-stimulated insulin secretion by neonatal rat pancreatic islet cells. Enhancement by sodium salicylate. Diabetes (1984) 0.84
Suppression of plasma catecholamines and flushing by clonidine in man. J Clin Endocrinol Metab (1978) 0.84
Oxygenation products of arachidonic acid: third messengers for insulin release. J Allergy Clin Immunol (1984) 0.83
Neuroendocrine modulation of calcitonin and parathyroid hormone in man. J Clin Endocrinol Metab (1978) 0.83
Unmasking of arachidonate-induced insulin release by removal of extracellular calcium. Arachidonic acid mobilizes cellular calcium in rat islets of Langerhans. Biochem Biophys Res Commun (1987) 0.83
Peritoneal fluid volume in endometriosis. Fertil Steril (1980) 0.83
Evidence of a role for GTP in the potentiation of Ca(2+)-induced insulin secretion by glucose in intact rat islets. J Clin Invest (1995) 0.83
Carrier screening for cystic fibrosis among Maryland obstetricians before and after the 1997 NIH Consensus Conference. Genet Test (2001) 0.82
Role for GTP in glucose-induced phospholipase C activation in pancreatic islets. Am J Physiol (1996) 0.82
Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol (1998) 0.81
Lack of specificity of melittin as a probe for insulin release mediated by endogenous phospholipase A2 or lipoxygenase. Biochem Pharmacol (1986) 0.81
Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes (1996) 0.81
A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics. Metabolism (1981) 0.80
Prostaglandin synthesis inhibitors reverse alpha-adrenergic inhibition of acute insulin response to glucose. Am J Physiol (1980) 0.80
Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. N Engl J Med (1977) 0.80
Improvement of insulin secretion in diabetics by a prostaglandin synthesis inhibitor. Adv Exp Med Biol (1979) 0.80
Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment. J Womens Health Gend Based Med (2000) 0.79
Marfan syndrome: neuropsychological aspects. Am J Med Genet (1988) 0.79
Purine nucleotide- and sugar phosphate-induced inhibition of the carboxyl methylation and catalysis of protein phosphatase-2A in insulin-secreting cells: protection by divalent cations. Biosci Rep (1998) 0.79
Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. Diabetes (1986) 0.79
Cyclosporin-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels. Biochem Pharmacol (1988) 0.79
Putative roles for lysophospholipids as mediators and lipoxygenase-mediated metabolites of arachidonic acid as potentiators of stimulus-secretion coupling: dual mechanisms of p-hydroxymercuribenzoic acid-induced insulin release. J Pharmacol Exp Ther (1986) 0.79
Feedback modulation of glucose-induced insulin secretion by arachidonic acid metabolites: possible molecular mechanisms and relevance to diabetes mellitus. Prostaglandins Med (1981) 0.79
Non-specific stimulatory effects of mastoparan on pancreatic islet nucleoside diphosphokinase activity: dissociation from insulin secretion. Biochem Pharmacol (1995) 0.79
p-Hydroxymercuribenzoic acid inhibits arachidonic acid esterification into two distinct pools and stimulates insulin release in intact rat islets. J Pharmacol Exp Ther (1986) 0.79
A role for the lipoxygenase pathway of arachidonic acid metabolism in glucose- and glucagon-induced insulin secretion. Life Sci (1983) 0.79
Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization. Endocrinology (1987) 0.79
Anticoagulation of autologous cord blood for neonatal resuscitation. Am J Obstet Gynecol (1982) 0.78
Applications and limitations of measurement of 15-keto,13,14-dihydro prostaglandin E2 in human blood by radioimmunoassay. Prostaglandins (1979) 0.78
Neuroendocrine tumours that secrete biologically active peptides and amines. Clin Endocrinol Metab (1977) 0.78
Prostaglandin E2 metabolite levels during diabetic ketoacidosis. Diabetes (1985) 0.78
Attitudes antecedent to transition to self-management of a chronic genetic disorder. Clin Genet (2008) 0.77
Ectopic secretion of chorionic gonadotropin by a lung carcinoma. Pituitary gonadotropin and subunit secretion and prolonged chemotherapeutic remission. Am J Med (1978) 0.77
A role for prostaglandins as mediators of alpha-adrenergic inhibition of the acute insulin response to glucose. Adv Prostaglandin Thromboxane Res (1980) 0.77
A classification of ectopic hormone-producing tumors. Ann N Y Acad Sci (1974) 0.77
Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions. Obstet Gynecol (1996) 0.77
Hypothesis: prostaglandins mediate defective glucose recognition in diabetes mellitus. Prostaglandins Med (1980) 0.77
Biologic activity of ectopic parathyroid hormone. N Engl J Med (1977) 0.77
Effects of inhibitors of guanine nucleotide synthesis on membrane potential and cytosolic free Ca2+ levels in insulin-secreting cells. Biochem Pharmacol (2000) 0.77
A re-interpretation of lipoxygenase-dependent insulin release: which metabolites of arachidonic acid, or none? Life Sci (1986) 0.77
The marker Xq28 syndrome ("Fragile-X SYndrome") in a retarded man with mitral valve prolapse. Johns Hopkins Med J (1982) 0.77
Sodium salicylate augments the plasma adrenocorticotropin and cortisol responses to insulin hypoglycemia in man. J Clin Endocrinol Metab (1982) 0.77